BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34167447)

  • 1. Phloretin inhibited the pathogenicity and virulence factors against
    Liu N; Zhang N; Zhang S; Zhang L; Liu Q
    Bioengineered; 2021 Dec; 12(1):2420-2431. PubMed ID: 34167447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of
    Romo JA; Pierce CG; Chaturvedi AK; Lazzell AL; McHardy SF; Saville SP; Lopez-Ribot JL
    mBio; 2017 Dec; 8(6):. PubMed ID: 29208749
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel Preclinical Study of Galloylquinic Acid Compounds from
    Al-Madboly LA; Abd El-Salam MA; Bastos JK; El-Shorbagy SH; El-Morsi RM
    Microbiol Spectr; 2022 Oct; 10(5):e0272421. PubMed ID: 35972130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of subinhibitory antifungal concentrations on extracellular hydrolases and biofilm production by Candida albicans recovered from Egyptian patients.
    El-Houssaini HH; Elnabawy OM; Nasser HA; Elkhatib WF
    BMC Infect Dis; 2019 Jan; 19(1):54. PubMed ID: 30651066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnesium deprivation affects cellular circuitry involved in drug resistance and virulence in Candida albicans.
    Hans S; Fatima Z; Hameed S
    J Glob Antimicrob Resist; 2019 Jun; 17():263-275. PubMed ID: 30659981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dracorhodin perchlorate inhibits biofilm formation and virulence factors of Candida albicans.
    Yang LF; Liu X; Lv LL; Ma ZM; Feng XC; Ma TH
    J Mycol Med; 2018 Mar; 28(1):36-44. PubMed ID: 29477784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro and In Vivo Antifungal Activity of Lichochalcone-A against Candida albicans Biofilms.
    Seleem D; Benso B; Noguti J; Pardi V; Murata RM
    PLoS One; 2016; 11(6):e0157188. PubMed ID: 27284694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-citronellol alters cell surface properties of Candida albicans to influence pathogenicity related traits.
    Sharma Y; Rastogi SK; Perwez A; Rizvi MA; Manzoor N
    Med Mycol; 2020 Jan; 58(1):93-106. PubMed ID: 30843057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Candida albicans biofilm and hyphae formation by biocompatible oligomers.
    Lee JH; Kim YG; Lee J
    Lett Appl Microbiol; 2018 Aug; 67(2):123-129. PubMed ID: 29885256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis.
    Gao M; Wang H; Zhu L
    Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiofilm and Antivirulence Activities of 6-Gingerol and 6-Shogaol Against
    Lee JH; Kim YG; Choi P; Ham J; Park JG; Lee J
    Front Cell Infect Microbiol; 2018; 8():299. PubMed ID: 30211127
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo and in vitro Pathogenesis and Virulence Factors of Candida albicans Strains Isolated from Cutaneous Candidiasis.
    Sadeghi G; Mousavi SF; Ebrahimi-Rad M; Mirabzadeh-Ardekani E; Eslamifar A; Shams-Ghahfarokhi M; Jahanshiri Z; Razzaghi-Abyaneh M
    Iran Biomed J; 2020 Sep; 24(5):324-32. PubMed ID: 32429646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Candida albicans biofilm formation and yeast-hyphal transition by 4-hydroxycordoin.
    Messier C; Epifano F; Genovese S; Grenier D
    Phytomedicine; 2011 Mar; 18(5):380-3. PubMed ID: 21353508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of serial systemic infection on
    Arita GS; Faria DR; Sakita KM; Rodrigues-Vendramini FA; Capoci IR; Kioshima ES; Bonfim-Mendonça PS; Svidzinski TI
    Future Microbiol; 2020 Sep; 15():1249-1263. PubMed ID: 33026881
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation between antifungal resistance and virulence factors in Candida albicans recovered from vaginal specimens.
    El-Houssaini HH; Elnabawy OM; Nasser HA; Elkhatib WF
    Microb Pathog; 2019 Mar; 128():13-19. PubMed ID: 30562603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of loureirin A against Candida albicans biofilms.
    Lin MY; Yuan ZL; Hu DD; Hu GH; Zhang RL; Zhong H; Yan L; Jiang YY; Su J; Wang Y
    Chin J Nat Med; 2019 Aug; 17(8):616-623. PubMed ID: 31472899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.
    Larkin E; Hager C; Chandra J; Mukherjee PK; Retuerto M; Salem I; Long L; Isham N; Kovanda L; Borroto-Esoda K; Wring S; Angulo D; Ghannoum M
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223375
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of Compounds Isolated from
    Meng L; Sun C; Zhang C; Song S; Sun X; Ju J; Deng Y
    Mar Drugs; 2019 Jul; 17(8):. PubMed ID: 31357504
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of Biofilm Formation by
    Lee JH; Kim YG; Khadke SK; Yamano A; Watanabe A; Lee J
    ACS Infect Dis; 2019 Jul; 5(7):1177-1187. PubMed ID: 31055910
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimicrobial photodynamic inactivation inhibits Candida albicans virulence factors and reduces in vivo pathogenicity.
    Kato IT; Prates RA; Sabino CP; Fuchs BB; Tegos GP; Mylonakis E; Hamblin MR; Ribeiro MS
    Antimicrob Agents Chemother; 2013 Jan; 57(1):445-51. PubMed ID: 23129051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.